Investigator
Kalim Ullah Mir
XGENOMES CORP. · funded by NIGMS, NCI, NHGRI
- Companies
- 2
- Grants
- 3
- Non-dilutive funding
- $1.1M
- First award
- Jun 1, 2025
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Sep 15, 2025.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- XGENOMES CORP.42momentum
OncologyGrant-only
- XGENOMES CORP.24momentum
OncologyGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R43
Achieving ultra-high-density, ultra-high-precision single molecule localization microscopy with whole-video deep learning architectures
$349kSep 15, 2025NIGMSXGENOMES CORP.NIH RePORTER · 11185009 (opens the source filing in a new tab)
- R43
A novel ctDNA analysis solution for the next-generation of liquid biopsy assays
$400kSep 1, 2025NCIXGENOMES CORP.NIH RePORTER · 11254540 (opens the source filing in a new tab)
- R43
Sequencing of epigenetic modifications across the genome by single-molecule detection of oligonucleotide binding kinetics
$398kJun 1, 2025NHGRIXGENOMES CORP.NIH RePORTER · 11185004 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources